APP and Alzheimer disease: In many of these transgenic AD models, a combination of human genes carrying the Swedish double mutation (KM670/671NL) for amyloid precursor protein (APP) and mutations of the Presenilin 1 (PSEN1) gene, such as the APPPS1 mouse strain, is used.